The two-state switch of chaperone BIP: A druggable target for endoplasmic reticulum stress in cancer and neurodegeneration
Ege Tıp Dergisi · 09.03.2026 · 65 (1) · 11-17
DOI: 10.19161/etd.1750148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ege Tıp Dergisi, online erschienen am 09.03.2026. Verfasst von Zekeriya Düzgün und 1 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Aim
The endoplasmic reticulum (ER) chaperone BiP is a central node in the unfolded protein response and a key therapeutic target in diseases driven by ER stress, such as cancer and neurodegeneration. However, therapeutic development is hampered by an incomplete understanding of the conformational dynamics that govern its substrate binding and release cycle.Materials and Methods: We performed a 100-nanosecond all-atomic molecular dynamics simulation of human BiP (PDB: 5e84) to characterize the flexibility of its substrate binding domain alpha (SBDα). We analyzed RMSD, inter-domain distances, and the free energy landscape to map its conformational states.
Results
Our simulations revealed that BiP exists in two distinct, low-energy conformational states: a predominant "extended" state (90% occupancy) and a transient "bent" state. The SBDα undergoes a rapid bending-restoring motion, with distances between key domains collapsing from ~25 Å to 3 Å within a 10 ns timescale. This motion represents a molecular switch with a moderate energy barrier of 25-30 kJ/mol, making it accessible at physiological temperatures.
Conclusions
The identified two-state conformational switch is a functionally critical feature that explains BiP's dynamic substrate handling. This molecular motion represents a "druggable" mechanism. Stabilizing either the extended or bent state with small molecules offers a tangible therapeutic strategy for modulating BiP activity, such as inhibiting its pro-survival function in cancer or enhancing its protective role in neurodegeneration.
Zitieren
APA
Düzgün, Z., & Eroğlu, Z. (2026). The two-state switch of chaperone BIP: A druggable target for endoplasmic reticulum stress in cancer and neurodegeneration. Ege Tıp Dergisi, 65(1), 11-17. https://doi.org/10.19161/etd.1750148
Vancouver
Düzgün Z, Eroğlu Z. The two-state switch of chaperone BIP: A druggable target for endoplasmic reticulum stress in cancer and neurodegeneration. Ege Tıp Dergisi. 2026;65(1):11-17. doi:10.19161/etd.1750148
BibTeX
@article{Dzgn2026,
author = {Düzgün, Zekeriya and Eroğlu, Zuhal},
title = {The two-state switch of chaperone BIP: A druggable target for endoplasmic reticulum stress in cancer and neurodegeneration},
journal = {Ege Tıp Dergisi},
year = {2026},
volume = {65},
number = {1},
pages = {11--17},
doi = {10.19161/etd.1750148}
}
EUVIMED